

Update
Wide differences in incidence–prevalence ratio by region
20 April 2020
20 April 2020 20 April 2020While important progress has been made against the global incidence–prevalence ratio—which, while declining from 11.2% in 2000 to 6.6% in 2010 and to 4.6% in 2018, still leaves the world not on track to end AIDS as a public health threat by 2030—the progress is uneven across regions.
Western and central Europe and North America, where treatment coverage is generally high and a comprehensive set of HIV prevention options is available to a large percentage of people at risk of HIV, had an incidence–prevalence ratio of 3.1% in 2018. Performance in other regions ranged from 3.9% in eastern and southern Africa, 4.6% in the Caribbean, 5.4% in both Latin America and Asia and the Pacific, 5.5% in western and central Africa, 8.0% in the Middle East and North Africa and 9.0% in eastern Europe and central Asia.